Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Link
http://link.springer.com/content/pdf/10.1186/1471-2407-11-404.pdf
Reference39 articles.
1. Kuderer N, Dale D, Crawford J, Cosler L, Lyman G: Mortality, Morbidity, and Cost Associated with Febrile Neutropenia in Adult Cancer Patients. CANCER. 2006, 106: 2258-2266. 10.1002/cncr.21847.
2. Brown R, Hutton J, Burrell A: Cost Effectiveness of Treatment Options in Advanced Breast Cancer in the UK. Pharmacoeconomics. 2001, 19: 1091-1102. 10.2165/00019053-200119110-00003.
3. Brown RE, Hutton J: Cost-utility model comparing docetaxel and paclitaxel in advanced breast cancer patients. Anticancer Drugs. 1998, 9: 899-907. 10.1097/00001813-199811000-00009.
4. Shayne M, Crawford J, Dale D, Culakova E, Lyman G, for the ANC Study Group: Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy. Breast Cancer Res Treat. 2006, 100: 255-262. 10.1007/s10549-006-9254-4.
5. Bonadonna G, Moliterni A, Zambetti M, Daidone M, Pilotti S, Gianni L, et al: 30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study. BMJ. 2005, 330: 217-222. 10.1136/bmj.38314.622095.8F.
Cited by 200 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Analysis of a lung cancer case with transient pseudo hypoglycemia after PEG-rhG-CSF treatment;Heliyon;2024-06
2. Leveraging G-CSF prescribing in the outpatient setting: considerations beyond clinical factors—a questionnaire study;Supportive Care in Cancer;2024-05-14
3. The Use of Granulocyte Colony-Stimulating Factor as Primary Prophylaxis in Patients Undergoing Chemotherapy: An Experience of Moroccan Oncologists;Cureus;2024-02-19
4. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of solid tumors;Cochrane Database of Systematic Reviews;2024-01-16
5. Efbemalenograstim alfa not inferior to pegfilgrastim in providing neutrophil support in women with breast cancer undergoing myelotoxic chemotherapy: results of a phase 2 randomized, multicenter, open-label trial;Supportive Care in Cancer;2024-01-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3